Your browser doesn't support javascript.
loading
Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study.
Davie, A; Cuyun Carter, G; Rider, A; Bailey, A; Lewis, K; Price, G; Ostojic, H; Ringeisen, F; Pivot, X.
Affiliation
  • Davie A; Eli Lilly and Co. Ltd, Windlesham, UK.
  • Cuyun Carter G; Eli Lilly and Co, Indianapolis, USA.
  • Rider A; Adelphi Real World, Bollington, Macclesfield, UK.
  • Bailey A; Adelphi Real World, Bollington, Macclesfield, UK.
  • Lewis K; Adelphi Real World, Bollington, Macclesfield, UK. Electronic address: katie.lewis@adelphigroup.com.
  • Price G; Eli Lilly and Co, Indianapolis, USA.
  • Ostojic H; Eli Lilly and Co, Indianapolis, USA.
  • Ringeisen F; Eli Lilly SA, Vernier, Geneva, Switzerland.
  • Pivot X; Paul Strauss Cancer Center, Strasbourg, France.
ESMO Open ; 6(4): 100226, 2021 08.
Article in En | MEDLINE | ID: mdl-34371379
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom